Haslinger B, Mandl-Weber S, Sellmayer A, Lederer S R, Sitter T
Medizinische Klinik, Klinikum Innenstadt, Ludwig-Maximilians-Universität, München, Deutschland.
Nephron. 2001 Apr;87(4):346-51. doi: 10.1159/000045941.
Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators. The present study was designed to assess the effect of glucose, the osmotic active compound in most commercially available peritoneal dialysis fluids, on the synthesis of the C-C chemokine monocyte chemoattractant protein-1 (MCP-1) in cultured HMC. The MCP-1 concentration in the cell supernatants was determined by enzyme-linked immunosorbent assay and the MCP-1 mRNA expression was examined using Northern blot analysis. Incubation of HMC with glucose (30-120 mM) resulted in a time- and concentration-dependent increase in MCP-1 protein secretion and mRNA expression. After 24 h the MCP-1 synthesis was increased from 2.8 +/- 0.46 to 4.2 +/- 0.32 ng/10(5) cells (n = 5, p < 0.05) in HMC treated with 60 mM glucose. In contrast, osmotic control media containing either the metabolically inert monosaccharide mannitol or NaCl did not influence MCP-1 production. The stimulating effect of high glucose on MCP-1 expression in HMC was mimicked by activation of protein kinase C (PKC) with the phorbol ester PMA (20 nM). Coincubation of the cells with glucose and the specific PKC inhibitor Ro 31-8220 completely blunted glucose-mediated MCP-1 expression. In summary, our results indicate that glucose induces MCP-1 synthesis by a PKC-dependent pathway. Since osmotic control media did not increase MCP-1 release, it is suggested that the effect of glucose is mainly related to metabolism and not to hyperosmolarity. These data may in part explain elevated steady-state levels of MCP-1 found in the dialysis effluent of continuous ambulatory peritoneal dialysis patients.
人腹膜间皮细胞(HMC)通过产生多种炎症介质的能力,对腹膜炎症过程的激活和控制发挥作用。本研究旨在评估葡萄糖(大多数市售腹膜透析液中的渗透活性化合物)对培养的HMC中C-C趋化因子单核细胞趋化蛋白-1(MCP-1)合成的影响。通过酶联免疫吸附测定法测定细胞上清液中的MCP-1浓度,并使用Northern印迹分析检测MCP-1 mRNA表达。用葡萄糖(30-120 mM)孵育HMC导致MCP-1蛋白分泌和mRNA表达呈时间和浓度依赖性增加。在60 mM葡萄糖处理的HMC中,24小时后MCP-1合成从2.8±0.46增加到4.2±0.32 ng/10(5)细胞(n = 5,p <0.05)。相反,含有代谢惰性单糖甘露醇或NaCl的渗透对照培养基不影响MCP-1的产生。用佛波酯PMA(20 nM)激活蛋白激酶C(PKC)可模拟高葡萄糖对HMC中MCP-1表达的刺激作用。细胞与葡萄糖和特异性PKC抑制剂Ro 31-8220共同孵育完全抑制了葡萄糖介导的MCP-1表达。总之,我们的结果表明葡萄糖通过PKC依赖性途径诱导MCP-1合成。由于渗透对照培养基未增加MCP-1释放,提示葡萄糖的作用主要与代谢有关,而非高渗性。这些数据可能部分解释了持续非卧床腹膜透析患者透析流出液中MCP-1稳态水平升高的原因。